Therapy Areas: Infectious Diseases
LakeShore Biopharma receives Nasdaq delisting determination letter
15 September 2025 - LakeShore Biopharma Co, Ltd (Nasdaq: LSB), a China-based global biopharmaceutical company that is involved in discovering, developing, manufacturing, and delivering new generations...
CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio
7 August 2025 - CorMedix Inc (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercialising therapeutic products for life-threatening diseases and conditions, has entered into a ...
INOVIO to release Q2 2025 financial results on 12 August
5 August 2025 - INOVIO (NASDAQ:INO), a US-based biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-associated diseases, cancers and...
Bavarian Nordic chikungunya vaccine enters Health Canada review process
22 July 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Tuesday that Health Canada has accepted its New Drug Submission for CHIKV VLP, a single-dose chikungunya vacci...
Ondine Biomedical completes world-first ICU study with Steriwave nasal therapy
21 July 2025 - Canadian life sciences company Ondine Biomedical Inc. (AIM: OBI) announced on Monday that it has completed patient recruitment for a pioneering 291-patient ICU study using its patented ...
Senhwa Biosciences reports first patient dosed in Pidnarulex (CX-5461) study in patients with advanced solid tumours
16 July 2025 - Senhwa Biosciences Inc (TPEx: 6492), a Taiwan-based drug development company involved in therapeutics for oncology, rare diseases, and infectious diseases, announced on Tuesday that its...